How did the Indian Pharma Market Achieve Self-Sufficiency?
A look at how India has achieved pharmaceutical self-sufficiency over the years - taking steps to become a global leader not only in the production of low-cost generic medicines but increasingly, end-to-end drug discovery and development.
The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80 per cent of the retail market, despite the fact that this country is the single largest provider of generic drugs globally.
India is supplying over 50% of global demand for various vaccines, 40% of generic demand in the United States, 25% of all medicine in United Kingdom and extremely low-cost medicine to African nations. Second, local players have enjoyed a dominant position driven by formulation development capabilities and early investments. Third, price levels are low, driven by intense competition. While India ranks tenth globally in terms of value, it is ranked third in volumes.
These characteristics present their own opportunities and challenges, download our free report by Infomineo for in-depth anaylsis on the evolution of India's Pharma market.
Related News
-
News Piramal to create screening facility to boost in-vitro biology capabilities
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities -
News Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch
Drug categories impacted by travel restrictions expected to see higher sales levels in FY22 -
News CPHI Trend Report: The Future of Indian API Manufacturing - Out Now!
Read this new CPHI Trend Report which, via interviews with key industry experts, explores the state of India's API manufacturing issue and how it is being impacted by the country's ambitious healthcare reform programme as well as efforts by the governm... -
News Bharat Biotech scales up Covaxin manufacturing capacity in India
The company will expand multiple facilities in Hyderabad and Bangalore to help reach its target of approximately 700 million doses per year of the COVID-19 vaccine -
News The PSCI supports the Musi River Revitalization Initiative, Hyderabad India
A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh -
News Gujarat, India's Pharma Hub
CPHI & P-MEC India and Global Business Reports are pleased to bring you the Gujarat Pharma 2020 report, sharing our view on the most attractive opportunities in the Indian pharma market. The report provides an outlook for the Gujarat region in India as... -
News POST COVID-19: Challenges and Opportunities for the Indian Pharmaceutical Industry
As Bill Gates had correctly predicted in 2015, the greatest threat to humanity was not nuclear missiles, but microbes. -
News VAV Lipids, India granted WHO GMP for phospholipid manufacturing facility.
We are glad to announce the approval of WHO GMP certification for our manufacturing facility, VAV Lipids. Securing this GMP is yet another significant milestone for the company with meaningful validation of our quality standards as we strive to be a gl...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance